Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Macaluso

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|July 5, 2017
Pharmacokinetic drug evaluation of paliperidone in the treatment of schizoaffective disorderMatthew Macaluso, Hannah Oliver, Zohaib Sohail
Medical Science Educator|August 30, 2021
Resident Training on Methylenetetrahydrofolate Reductase: a National SurveyThien Vu, Rosalee Zackula, Matthew Macaluso
Journal of Psychiatric Practice|September 9, 2015
Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder: Part 1Sheldon Preskorn, Alexandra Flynn, Matthew Macaluso
Journal of Psychiatric Practice|January 28, 2016
Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 2: Preclinical and Early Phase Human Proof of Concept StudiesMatthew Macaluso, Alexandra Flynn, Sheldon Preskorn
Journal of Psychiatric Practice|April 29, 2016
Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 4: Case Report DataMatthew Macaluso, Alexandra Flynn, Sheldon Preskorn
The Primary Care Companion for CNS Disorders|January 13, 2022
Use of the ECHO Model to Improve Outcomes for Depressed Patients During the Era of COVID-19Kimberly Smith, Rebekah Kummer, Matthew Macaluso
Journal of Psychiatric Practice|July 13, 2015
How Commonly Used Inclusion and Exclusion Criteria in Antidepressant Registration Trials Affect Study EnrollmentSheldon H Preskorn, Matthew Macaluso, Madhukar Trivedi
Journal of Psychiatric Practice|March 15, 2017
Tardive Dyskinesia: A Historical PerspectiveMatthew Macaluso, Alexandra Flynn, Sheldon H Preskorn
Journal of Psychiatric Practice|July 22, 2011
Phase I trials: from traditional to newer approaches part IIMatthew Macaluso, Michael Krams, Sheldon H Preskorn
Journal of Psychiatric Practice|May 19, 2011
Phase I trials: from traditional to newer approaches. Part IMatthew Macaluso, Michael Krams, Sheldon H Preskorn
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Expert Opinion on Drug Metabolism & Toxicology|July 5, 2017
Pharmacokinetic drug evaluation of paliperidone in the treatment of schizoaffective disorderMatthew Macaluso, Hannah Oliver, Zohaib Sohail
Medical Science Educator|August 30, 2021
Resident Training on Methylenetetrahydrofolate Reductase: a National SurveyThien Vu, Rosalee Zackula, Matthew Macaluso
Journal of Psychiatric Practice|September 9, 2015
Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder: Part 1Sheldon Preskorn, Alexandra Flynn, Matthew Macaluso
Journal of Psychiatric Practice|January 28, 2016
Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 2: Preclinical and Early Phase Human Proof of Concept StudiesMatthew Macaluso, Alexandra Flynn, Sheldon Preskorn
Journal of Psychiatric Practice|April 29, 2016
Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 4: Case Report DataMatthew Macaluso, Alexandra Flynn, Sheldon Preskorn
The Primary Care Companion for CNS Disorders|January 13, 2022
Use of the ECHO Model to Improve Outcomes for Depressed Patients During the Era of COVID-19Kimberly Smith, Rebekah Kummer, Matthew Macaluso
Journal of Psychiatric Practice|July 13, 2015
How Commonly Used Inclusion and Exclusion Criteria in Antidepressant Registration Trials Affect Study EnrollmentSheldon H Preskorn, Matthew Macaluso, Madhukar Trivedi
Journal of Psychiatric Practice|March 15, 2017
Tardive Dyskinesia: A Historical PerspectiveMatthew Macaluso, Alexandra Flynn, Sheldon H Preskorn
Journal of Psychiatric Practice|July 22, 2011
Phase I trials: from traditional to newer approaches part IIMatthew Macaluso, Michael Krams, Sheldon H Preskorn
Journal of Psychiatric Practice|May 19, 2011
Phase I trials: from traditional to newer approaches. Part IMatthew Macaluso, Michael Krams, Sheldon H Preskorn
Pageof 7